Evidence map›Paper›PMID 10235609›Full record

ArticleDigestive diseases and sciences1999

Copper-indomethacinate associated with zwitterionic phospholipids prevents enteropathy in rats: effect on inducible NO synthase.

V Bertrand, F Guessous, A L Le Roy, B Viossat, H Fessi, A El Abbouyi, J P Giroud, M Roch-Arveiller

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Development of copper based drugs, radiopharmaceuticals and medical materials.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2012
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

V BertrandDépartement de Pharmacologie, CNRS URA 1534, Hôpital Cochin, Paris, France.
F Guessous
A L Le Roy
B Viossat
H Fessi
A El Abbouyi
J P Giroud
M Roch-Arveiller
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intestinal toxicity exerted by indomethacin was compared to that induced by copper-indomethacinate, free or associated to zwitterionic phospholipids. A single high dose of indomethacin (15 or 20 mg/kg), copper-indomethacinate (15 or 20 mg/kg), or copper-indomethacinate liposomes or nanocapsules (15 mg/kg) was orally administered. Then 24 hr later jejunoileal tissue was taken for macroscopic observation, ex vivo nitrite production, and determination of myeloperoxydase and iNOS activities. Antiinflammatory activity of the drugs was investigated using the carrageenan-induced paw edema model. Indomethacin induced penetrating ulcerations of the intestine that were maximal at hour 24. Copper-indomethacinate induced significantly less ulceration than indomethacin with no significant difference in MPO and iNOS activities. The injurious action of indomethacin on the small intestine was further reduced when copper-indomethacinate was administered as the phospholipid-associated state while similar anti-inflammatory action was observed on rat paw edema. The antiulcerogen effect of copper-indomethacinate seems to be linked to its free radical scavenging effect without any modification of nitric oxide release.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalCopperIndomethacinIntestine, SmallJejunumLiposomesMaleNitric Oxide SynthaseNitric Oxide Synthase Type IIOrganometallic CompoundsPeroxidasePhospholipidsRatsRats, Sprague-DawleyUlcerAnti-Inflammatory Agents, Non-SteroidalCoppercupric(indomethacinate)4complexIndomethacinLiposomesNitric Oxide SynthaseNitric Oxide Synthase Type IINos2 protein, ratOrganometallic CompoundsPeroxidasePhospholipids

Identifiers

PMID10235609
OpenAlexW2256533045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.